平安中证港股医药ETF联接A(019598)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-9,045,063.04 |
19,649,935.36 |
19,737,876.56 |
-11,957,140.42 |
| 利息合计 |
15,197.16 |
50,253.59 |
17,842.27 |
25,890.57 |
| 其中:存款利息收入 |
15,197.16 |
50,253.59 |
17,842.27 |
25,890.57 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-962,148.88 |
13,142,749.66 |
5,128,045.94 |
-13,582,282.65 |
| 其中:股票投资收益 |
- |
- |
- |
- |
| 基金投资收益 |
-969,669.64 |
13,143,782.90 |
5,129,148.41 |
-13,607,628.40 |
| 债券投资收益 |
7,520.76 |
-1,033.24 |
-1,102.47 |
25,345.75 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
- |
- |
- |
- |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-8,108,019.26 |
6,264,519.63 |
14,470,348.36 |
1,564,073.42 |
| 其他收入 |
9,907.94 |
192,412.48 |
121,639.99 |
35,178.24 |
| 费用 |
145,263.22 |
261,722.24 |
91,318.38 |
174,893.68 |
| 管理人报酬 |
9,717.56 |
21,634.11 |
8,747.56 |
17,269.52 |
| 基金托管费 |
1,943.56 |
4,326.84 |
1,749.57 |
3,453.91 |
| 销售服务费 |
78,772.74 |
164,970.66 |
62,341.38 |
121,010.21 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
53,556.09 |
23,375.46 |
- |
33,160.04 |
| 利润总额 |
-9,190,326.26 |
19,388,213.12 |
19,646,558.18 |
-12,132,034.10 |